AZBio and SynCardia on ABC15
By: Christina Estes ABC15
Tucson-based SynCardia Systems was among the companies showcased at the annual AZ Bio Expo.It’s a chance for bioscience and technology companies to learn more about funding opportunities and hear success stories.According to the Arizona BioIndustry Association, our state is getting more federal funding for research and seeing higher job growth in the bioscience industry compared to the national average.“Tucson and Arizona are the international headquarters for the world’s only total artificial heart,” said Don Isaacs, SynCardia vice president of communications. “They replace the exact same parts of the heart as if you had a heart transplant.”The SynCardia heart is made in Arizona using bio-compatible material also made here. Isaacs says they have 82 employees in Arizona and about 80 people currently using the heart. The device is considered a bridge for people awaiting a transplant or a life saver for those who will not get transplants due to age or medical conditions.“There’s only 2,200 hearts available per year in the United States and the level of donors has been the same for the last twenty years,” Isaacs said.SynCardia is also undergoing FDA clinical trials for the world’s first wearable power supply for their temporary artificial heart.
(Republished with permission from ABC15)
Read more: http://www.abc15.com/dpp/news/region_southeast_valley/tempe/Arizona-company-SynCardia-Systems-makes-worlds-first-total-temporary-artificial-heart#ixzz2X99ewU3x
2017 Fast Lane Honoree NuvOx Pharma
The Human Brain is our most complex organ. Everything we are and everything we do is controlled by our brain. NuvOx Pharma is a biotechnology company based in Tucson, Arizona that is developing an innovative nanotechnology for oxygen delivery to treat life-threatening diseases where hypoxia plays a role like cancer, stroke, sickle cell disease, hemorrhagic shock, traumatic brain injury, and heart attack. Hypoxia is when there is a deficiency in the amount of oxygen reaching the tissues. NuvOx is currently in clinical trials for brain cancer and stroke.
Leadership Conversation with Nobel Laureate Leland Hartwell, PhD (2014)
How will we create sustainable health? What innovations can make a difference? What is the role of education? Lee Hartwell, PhD, is the Virginia G. Piper Chair in Personalized Medicine at the Center for Sustainable Health, Biodesign Institute, Arizona State University. At the Center his work focuses on creating effective learning environments. The first is a course required for all K-8 teachers, Sustainability Science for Teachers and the second is Project Honey Bee, an interdisciplinary research project to validate wearable devices for ambulatory patient management. He also oversees a project to develop biomarkers for the clinical management of many diseases at the Chang Gung Memorial Hospital and University in Taipei, Taiwan. Dr. Hartwell was awarded the 2001 Nobel Prize in Physiology or Medicine for identifying genes that control cell division in yeast.
The Precision Medicine Initiative®
Dr. Akinlolu (“Lolu”) Ojo, Associate Vice President for Clinical
Research and Global Health Initiatives, University of Arizona Health Sciences
Akinlolu O. Ojo, MD, MPH, PhD, MBA, is the associate vice president for clinical research and global health initiatives at the University of Arizona Health Sciences and a professor of medicine in the UA College of Medicine – Tucson with a joint appointment as professor of health promotion sciences in the UA Mel and Enid Zuckerman College of Public Health.